Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
30 hedge funds and large institutions have $6.88M invested in Reunion Neuroscience Inc. Common Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
11% more funds holding
Funds holding: 27 → 30 (+3)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
44% less capital invested
Capital invested by funds: $12.2M → $6.88M (-$5.34M)
Top Buyers
| 1 |
OPOWM
One Plus One Wealth Management
Jupiter,
Florida
|
+$380K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$20.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.66K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.12K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$762K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$437K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$287K |
| 4 |
Millennium Management
New York
|
-$53K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$39.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
APA
26
American Portfolios Advisors
Holbrook,
New York
| $6 | – | – | – |
|
|
WIM
27
Westside Investment Management
Santa Monica,
California
| $1 | +$1.7K | +340 | New |
|
|
O
28
OrbiMed
New York
| – | -$762K | -115,386 | Closed |
|
|
29
Point72 Asset Management
Stamford,
Connecticut
| – | -$437K | -65,924 | Closed |
|
|
30
Millennium Management
New York
| – | -$53K | -7,849 | Closed |
|
|
ETC
31
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| – | -$1K | -171 | Closed |
|
32
Group One Trading
Chicago,
Illinois
| – | +$55 | +11 | New |
|
33
Osaic Holdings
Scottsdale,
Arizona
| – | +$500 | +100 | New |
|
REUN Hedge Fund Activity: Q2 2022 in Review
30 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q2 2022, worth a combined $6.88M — down 44% from $12.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new REUN positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was One Plus One Wealth Management, opening a new position worth an estimated $380K. The largest seller was OrbiMed, exiting entirely with an estimated $762K sold.
- 30 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q2 2022, up from 27 in Q1 2022.
- Funds reported $6.88M of Reunion Neuroscience Inc. Common Shares stock for Q2 2022, down 44% quarter-over-quarter.
- 8 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q2 2022 and 5 closed out, a net change of +3 holders.
- The largest Reunion Neuroscience Inc. Common Shares buyer in Q2 2022 was One Plus One Wealth Management, an estimated $380K added.
- The largest Reunion Neuroscience Inc. Common Shares seller in Q2 2022 was OrbiMed, an estimated $762K sold.
Based on aggregated 13F filings for Q2 2022.